The University of Chicago Header Logo

Connection

Thomas N. Krausz to Pleural Neoplasms

This is a "connection" page, showing publications Thomas N. Krausz has written about Pleural Neoplasms.
Connection Strength

2.446
  1. Immunohistochemical evaluation of nuclear 5-hydroxymethylcytosine (5-hmC) accurately distinguishes malignant pleural mesothelioma from benign mesothelial proliferations. Mod Pathol. 2019 03; 32(3):376-386.
    View in: PubMed
    Score: 0.551
  2. BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma. Hum Pathol. 2017 02; 60:86-94.
    View in: PubMed
    Score: 0.480
  3. BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma. Hum Pathol. 2015 Nov; 46(11):1670-8.
    View in: PubMed
    Score: 0.441
  4. Molecular analyses, morphology and immunohistochemistry together differentiate pleural synovial sarcomas from mesotheliomas: clinical implications. Anticancer Res. 2002 Nov-Dec; 22(6B):3443-8.
    View in: PubMed
    Score: 0.182
  5. Comparison of Nuclear Grade, Necrosis, and Histologic Subtype Between Biopsy and Resection in Pleural Malignant Mesothelioma: An International Multi-Institutional Analysis. Am J Clin Pathol. 2021 Nov 08; 156(6):989-999.
    View in: PubMed
    Score: 0.170
  6. MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma. Mod Pathol. 2020 02; 33(2):245-254.
    View in: PubMed
    Score: 0.145
  7. Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays. Hum Pathol. 2019 05; 87:11-17.
    View in: PubMed
    Score: 0.141
  8. Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study. Mod Pathol. 2018 04; 31(4):598-606.
    View in: PubMed
    Score: 0.131
  9. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2013 May; 137(5):647-67.
    View in: PubMed
    Score: 0.090
  10. Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2009 Aug; 133(8):1317-31.
    View in: PubMed
    Score: 0.073
  11. p53 expression is common in malignant mesothelioma. Histopathology. 1992 Oct; 21(4):331-4.
    View in: PubMed
    Score: 0.023
  12. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc Natl Acad Sci U S A. 2010 Jul 13; 107(28):12611-6.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.